AMGNTICKER
Amgen Inc.
Congress has disclosed 72 buys and 52 sells of AMGN (Amgen Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
72
Buy
52
Sell
+20
Net
37
Active politicians
Round-trip watch Still on the books
Members who disclosed buying AMGN and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Virginia Foxx | 2024-12-06 | $258.69 | $466.01 | +80.1% | in profit |
| Jared Moskowitz | 2025-04-16 | $270.41 | $466.01 | +72.3% | in profit |
| Jefferson Shreve | 2025-04-11 | $273.60 | $466.01 | +70.3% | in profit |
| Cliff Bentz | 2025-06-06 | $280.22 | $466.01 | +66.3% | in profit |
| Marjorie Taylor Greene | 2025-10-24 | $283.88 | $466.01 | +64.2% | in profit |
| Rohit Khanna | 2026-02-24 | $377.79 | $466.01 | +23.4% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
26.84
≈ in line with
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$466.01 ÷ $17.36 = 26.84
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
17.56
▲ pricier than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$466.01 ÷ $26.53 = 17.56
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
16.48
≈ in line with
Health (median 16.2)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($252.1B + $40.8B net debt) ÷ $17.8B = $292.9B ÷ $17.8B = 16.48
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
126 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| David Taylor | House | BUY ◆ insider divergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-09-22 | 9 days | -0.7% | $1K–$15K 0.3% of NW |
53.9 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · Dave's IRA @ Schwab (Home Grown) | 2026-08-26 | 8 days | +0.9% | $1K–$15K 0.3% of NW |
50.5 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2026-08-26 | 8 days | +0.9% | $1K–$15K 0.3% of NW |
50.5 | ↗ filing |
| Sheldon Whitehouse | Senate | SELL ◆ insider convergence · moderate | Spouse | 2026-08-12 | 21 days | +7.0% | $1K–$15K | 99.9 | ↗ eFD |
| David Taylor | House | BUY ◆ insider divergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-06-05 | 6 days | +1.3% | $1K–$15K 0.3% of NW |
11.7 | ↗ filing |
| Maria Elvira Salazar | House | SELL ◆ insider convergence · moderate | Self · UBS Brokerage Account | 2026-04-17 | 14 days | -7.2% | $15K–$50K 1.6% of NW |
59.0 | ↗ filing |
| Alan Armstrong | Senate | OTHER | Self | 2026-03-27 | 116 days | +5.8% | $15K–$50K | 99.6 | ↗ eFD |
| Maria Elvira Salazar | House | BUY ◆ insider divergence · moderate | Self · UBS IRA Account | 2026-03-24 | 8 days | +1.4% | $15K–$50K 1.6% of NW |
93.1 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-02-26 | 7 days | -3.1% | $1K–$15K 0.3% of NW |
7.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-02-24 | 8 days | -0.9% | $15K–$50K | 48.8 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-01-29 | 1 days | -0.3% | $1K–$15K 0.3% of NW |
9.6 | ↗ filing |
| David Taylor | House | BUY ◆ insider divergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-01-16 | 14 days | +3.5% | $1K–$15K 0.3% of NW |
17.2 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2025-12-03 | 2 days | -4.5% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2025-12-03 | 2 days | -4.5% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence · moderate | Self | 2025-10-24 | 3 days | -0.2% | $1K–$15K | 9.4 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence · moderate | Spouse · Charles Schwab Brokerage Account 924 | 2025-09-25 | 6 days | +10.1% | $1K–$15K 0.1% of NW |
84.8 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2025-09-11 | 1 days | -2.2% | $1K–$15K | 11.6 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence · moderate | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-24 | 50 days | +4.3% | $1K–$15K 0.1% of NW |
98.1 | ↗ filing |
| Cliff Bentz | House | BUY ◆ insider divergence | Spouse · Charles Schwab SEP-IRA | 2025-06-06 | 25 days | +0.1% | $1K–$15K 0.2% of NW |
99.4 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2025-05-14 | 1 days | +3.6% | $1K–$15K | 33.6 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | -1.1% | $15K–$50K <0.1% of NW |
28.6 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self · Marjorie IRA | 2025-05-05 | 1 days | -3.4% | $1K–$15K | 50.5 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Child · Morgan Stanley Active Assets (5) | 2025-04-16 | 14 days | +2.9% | $1K–$15K 0.3% of NW |
51.2 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-04-16 | 14 days | +2.9% | $1K–$15K 0.3% of NW |
51.2 | ↗ filing |
| Thomas Tuberville | Senate | OTHER | Joint | 2025-04-15 | 477 days | +43.5% | $15K–$50K | 99.5 | ↗ eFD |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-04-11 | 14 days | -1.8% | $15K–$50K <0.1% of NW |
59.2 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-02-24 | 5 days | -0.5% | $15K–$50K <0.1% of NW |
69.2 | ↗ filing |
| Daniel Meuser | House | SELL ◆ insider convergence · moderate | Spouse · Schwab Brokerage Account | 2025-02-11 | 0 days | 0.0% | $1K–$15K <0.1% of NW |
62.3 | ↗ filing |
| Emily Randall | House | SELL ◆ insider convergence · moderate | Spouse · Garret D. Leahey 2019 Irrevocable F/B/O Alison Leahey | 2025-01-06 | 35 days | +14.0% | $1K–$15K | 99.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-12-18 | 20 days | +1.3% | $1K–$15K | 26.5 | ↗ filing |
| Virginia Foxx | House | BUY | Self | 2024-12-06 | 31 days | -5.1% | $1K–$15K 0.2% of NW |
98.1 | ↗ filing |
| Julia Letlow | House | SELL | Self · Merrill Lynch Investment Account #025 | 2024-11-19 | 265 days | +3.6% | $1K–$15K 1.0% of NW |
32.3 | ↗ filing |
| Julia Letlow | House | BUY | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | -7.2% | $1K–$15K 1.0% of NW |
69.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-10-14 | 24 days | -0.8% | $1K–$15K | 31.8 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Traditional IRA | 2024-08-07 | 9 days | — | $50K–$100K 1.0% of NW |
58.9 | ↗ filing |
| Scott Franklin | House | BUY | Spouse · Fidelity Roth IRA C: Our broker purchased shares of 29 stocks in my spouse's Roth IRA on 8/7/24 in o | 2024-08-07 | 285 days | — | $1K–$15K 0.1% of NW |
27.4 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Roth IRA | 2024-08-02 | 14 days | — | $1K–$15K 0.1% of NW |
63.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-07-02 | 34 days | — | $1K–$15K | 52.4 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
6.1 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
0.3 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence | Spouse | 2024-01-02 | 2 days | — | $15K–$50K 0.7% of NW |
51.1 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider convergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
75.9 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Self · Morgan Stanley Active Assets (1) | 2023-07-14 | 395 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Kathy Manning | House | BUY | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
24.8 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-04-12 | 21 days | — | $1K–$15K <0.1% of NW |
24.8 | ↗ filing |
| Michael Burgess | House | BUY | Self | 2023-04-05 | 5 days | — | $15K–$50K 0.7% of NW |
96.4 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-03-27 | 10 days | — | $1K–$15K <0.1% of NW |
2.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-03-06 | 31 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-02-22 | 13 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR | Child | 2023-02-14 | 15 days | — | $1K–$15K | 86.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-01-27 | 10 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-12-09 | 26 days | — | $1K–$15K <0.1% of NW |
2.6 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-10-19 | 15 days | — | $1K–$15K <0.1% of NW |
13.4 | ↗ filing |
| Kathy Manning | House | SELL | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-10-12 | 23 days | — | $1K–$15K 0.1% of NW |
4.5 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2022-09-26 | 9 days | — | $1K–$15K 0.1% of NW |
19.6 | ↗ filing |
| Richard Allen | House | BUY | Spouse · R.W. Allen & Associates, Inc. > RWA&A - Securities | 2022-08-18 | 18 days | — | $15K–$50K 1.4% of NW |
96.9 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-08-03 | 34 days | — | $1K–$15K 0.1% of NW |
5.5 | ↗ filing |
| Kathy Manning | House | SELL | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
19.6 | ↗ filing |
| Kathy Manning | House | SELL | Spouse · MV Capital - GST Exempt Trust #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Kathy Manning | House | BUY | Joint · Charles Schwab - O'Shaughnessy Asset Management | 2022-07-20 | 13 days | — | $1K–$15K 0.1% of NW |
26.5 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-05-11 | 28 days | — | $1K–$15K <0.1% of NW |
5.5 | ↗ filing |
| Earl Blumenauer | House | SELL | Self | 2022-03-14 | 0 days | — | $1K–$15K 0.1% of NW |
26.5 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-03-03 | 39 days | — | $1K–$15K <0.1% of NW |
28.4 | ↗ filing |
| Earl Blumenauer | House | BUY | Self | 2022-02-24 | 18 days | — | $1K–$15K 0.1% of NW |
50.5 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Self | 2022-02-22 | 2 days | — | $1K–$15K | 59.5 | ↗ filing |
| John Rutherford | House | SELL | Self | 2022-02-17 | 0 days | — | $1K–$15K 0.8% of NW |
52.4 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2022-02-11 | 24 days | — | $1K–$15K 0.1% of NW |
59.5 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Joint | 2021-07-19 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Kathy Manning | House | BUY | Self | 2021-04-30 | 6 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Carol Devine Miller | House | BUY | Spouse | 2021-03-04 | 28 days | — | $15K–$50K 0.1% of NW |
97.2 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Kathy Manning | House | SELL | Self | 2021-01-15 | 18 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Kathy Manning | House | SELL | Spouse | 2021-01-15 | 18 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-10-22 | 13 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-10-08 | 27 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Carol Devine Miller | House | BUY | Spouse | 2020-07-28 | 2 days | — | $15K–$50K 0.1% of NW |
99.5 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2020-05-29 | 7 days | — | $1K–$15K | 19.6 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2020-05-29 | 7 days | — | $1K–$15K | 19.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-05-15 | 24 days | — | $1K–$15K <0.1% of NW |
26.5 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2020-05-01 | 33 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2020-01-14 | 21 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Michael John Gallagher | House | SELL | Spouse | 2020-01-09 | 4 days | — | $1K–$15K | 75.9 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2019-11-20 | 14 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2019-11-07 | 27 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Richard Allen | House | BUY | Spouse · LIVTR | 2019-09-27 | 8 days | — | $15K–$50K 1.4% of NW |
98.1 | ↗ filing |
| Bill Flores | House | BUY | Self | 2019-09-19 | 15 days | — | $1K–$15K | 31.8 | ↗ filing |
| Richard Allen | House | BUY | Self · R.W. Allen & Associates, Inc. > RWA&A - Securities | 2019-08-29 | 7 days | — | $15K–$50K 1.4% of NW |
99.8 | ↗ filing |
| Bill Flores | House | SELL | Self | 2019-05-08 | 28 days | — | $1K–$15K | 40.4 | ↗ filing |
| Bill Flores | House | BUY | Self | 2019-03-25 | 9 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2018-12-18 | 27 days | — | $1K–$15K | 15.7 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2018-12-06 | 39 days | — | $1K–$15K | 22.3 | ↗ filing |
| Gary Palmer | House | SELL | Joint | 2018-10-05 | 0 days | — | $1K–$15K 0.3% of NW |
84.3 | ↗ filing |
| Gary Palmer | House | SELL | Spouse | 2018-10-05 | 0 days | — | $1K–$15K 0.3% of NW |
84.3 | ↗ filing |
| Gary Palmer | House | SELL | Self | 2018-10-05 | 0 days | — | $1K–$15K 0.3% of NW |
84.3 | ↗ filing |
| Gary Palmer | House | BUY | Self | 2018-08-06 | 0 days | — | $1K–$15K 0.3% of NW |
88.5 | ↗ filing |
| Gary Palmer | House | BUY | Joint | 2018-07-12 | 0 days | — | $1K–$15K 0.3% of NW |
94.6 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2017-11-09 | 29 days | — | $1K–$15K | 40.4 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2017-10-05 | 43 days | — | $1K–$15K 0.1% of NW |
8.6 | ↗ filing |
| John Rutherford | House | BUY | Self | 2017-07-17 | 14 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
| Gary Palmer | House | BUY | Spouse | 2017-04-04 | 0 days | — | $1K–$15K 0.3% of NW |
98.8 | ↗ filing |
| David McKinley | House | SELL | Self | 2016-12-27 | 7 days | — | $1K–$15K | 10.6 | ↗ filing |
| David McKinley | House | SELL | Joint | 2016-12-21 | 13 days | — | $15K–$50K | 30.7 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2016-10-11 | 197 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-09-01 | 30 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-06-01 | 30 days | — | $1K–$15K | 75.9 | ↗ filing |
| Debbie Dingell | House | BUY | Spouse | 2016-03-21 | 7 days | — | $1K–$15K 0.1% of NW |
94.6 | ↗ filing |
| Debbie Dingell | House | BUY | Spouse | 2016-02-23 | 6 days | — | $15K–$50K 0.3% of NW |
99.8 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2016-02-01 | 36 days | — | $1K–$15K | 86.8 | ↗ filing |
| Frank LoBiondo | House | BUY | Spouse | 2015-12-01 | 232 days | — | $1K–$15K | 75.9 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2015-11-18 | 15 days | — | $15K–$50K 0.2% of NW |
30.7 | ↗ filing |
| David McKinley | House | BUY | Joint | 2015-09-18 | 13 days | — | $15K–$50K | 56.6 | ↗ filing |
| David McKinley | House | BUY | Joint | 2015-09-18 | 13 days | — | $1K–$15K | 40.4 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2015-05-11 | 30 days | — | $1K–$15K | 22.3 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2015-01-15 | 18 days | — | $1K–$15K | 40.4 | ↗ filing |
| Jim McDermott | House | SELL | Self | 2014-12-03 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| David McKinley | House | BUY | Self | 2014-08-19 | 10 days | — | $1K–$15K | 75.9 | ↗ filing |
| Raúl Grijalva | House | BUY | Spouse | 2014-06-16 | 23 days | — | $1K–$15K | 75.9 | ↗ filing |
| Katherine Clark | House | BUY | Self | 2014-03-13 | 252 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Katherine Clark | House | BUY | Self | 2014-02-20 | 273 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | BUY | Self | 2014-02-05 | 288 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Nick Rahall | House | SELL | Self | 2014-01-23 | 0 days | — | $1K–$15K | 40.4 | ↗ filing |
| Nick Rahall | House | SELL | Self | 2014-01-08 | 0 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in AMGN — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
16
Congress trades with insider convergence
20
…with insider divergence
30
Insider open-market trades
Of the congressional trades in AMGN, 16 coincided with corporate insiders moving the same way within 60 days, and 20 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-13 | Khosla Rachna | Other | SELL | $521K | ↗ EDGAR |
| 2026-08-11 | Khosla Rachna | Other | SELL | $825K | ↗ EDGAR |
| 2026-08-06 | Grygiel Nancy A. | Other | SELL | $792K | ↗ EDGAR |
| 2026-08-06 | Grygiel Nancy A. | Other | SELL | $402K | ↗ EDGAR |
| 2026-08-06 | Miller Derek | Other | SELL | $833K | ↗ EDGAR |
| 2026-08-06 | Miller Derek | Other | SELL | $733K | ↗ EDGAR |
| 2026-05-04 | Grygiel Nancy A. | Other | SELL | $400K | ↗ EDGAR |
| 2026-02-26 | Santos Esteban | Other | SELL | $11.6M | ↗ EDGAR |
| 2026-02-26 | Santos Esteban | Other | SELL | $9.2M | ↗ EDGAR |
| 2026-02-19 | Busch Matthew C. | Other | SELL | $376K | ↗ EDGAR |
| 2025-11-20 | Grygiel Nancy A. | Other | SELL | $506K | ↗ EDGAR |
| 2025-11-20 | Grygiel Nancy A. | Other | SELL | $553K | ↗ EDGAR |
| 2025-11-12 | Gordon Murdo | Other | SELL | $2.3M | ↗ EDGAR |
| 2025-11-12 | Khosla Rachna | Other | SELL | $299K | ↗ EDGAR |
| 2025-08-20 | Grygiel Nancy A. | Other | SELL | $376K | ↗ EDGAR |
| 2025-06-05 | Khosla Rachna | Other | SELL | $435K | ↗ EDGAR |
| 2025-05-02 | Busch Matthew C. | Other | SELL | $280K | ↗ EDGAR |
| 2025-02-21 | REESE DAVID M | C-suite | SELL | $7.7M | ↗ EDGAR |
| 2025-02-19 | Miller Derek | Other | SELL | $448K | ↗ EDGAR |
| 2025-02-19 | REESE DAVID M | C-suite | SELL | $2.6M | ↗ EDGAR |
| 2025-02-19 | Santos Esteban | Other | SELL | $2.6M | ↗ EDGAR |
| 2025-02-18 | Miller Derek | Other | SELL | $146K | ↗ EDGAR |
| 2025-02-11 | Gordon Murdo | Other | SELL | $2.6M | ↗ EDGAR |
| 2025-02-07 | Graham Jonathan P | Other | SELL | $7.3M | ↗ EDGAR |
| 2025-02-05 | Grygiel Nancy A. | Other | SELL | $484K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-22 | David Taylor | BUY | $1K–$15K |
| Congress | 2026-08-26 | David Taylor | SELL | $1K–$15K |
| Congress | 2026-08-26 | David Taylor | SELL | $1K–$15K |
| ◆ insider | 2026-08-13 | Khosla Rachna Other | SELL | $521K |
| Congress | 2026-08-12 | Sheldon Whitehouse | SELL | $1K–$15K |
| ◆ insider | 2026-08-11 | Khosla Rachna Other | SELL | $825K |
| ◆ insider | 2026-08-06 | Grygiel Nancy A. Other | SELL | $792K |
| ◆ insider | 2026-08-06 | Grygiel Nancy A. Other | SELL | $402K |
| ◆ insider | 2026-08-06 | Miller Derek Other | SELL | $833K |
| ◆ insider | 2026-08-06 | Miller Derek Other | SELL | $733K |
| Congress | 2026-06-05 | David Taylor | BUY | $1K–$15K |
| ◆ insider | 2026-05-04 | Grygiel Nancy A. Other | SELL | $400K |
| Congress | 2026-04-17 | Maria Elvira Salazar | SELL | $15K–$50K |
| Congress | 2026-03-27 | Alan Armstrong | OTHER | $15K–$50K |
| Congress | 2026-03-24 | Maria Elvira Salazar | BUY | $15K–$50K |
| Congress | 2026-02-26 | David Taylor | SELL | $1K–$15K |
| ◆ insider | 2026-02-26 | Santos Esteban Other | SELL | $11.6M |
| ◆ insider | 2026-02-26 | Santos Esteban Other | SELL | $9.2M |
| Congress | 2026-02-24 | Rohit Khanna | BUY | $15K–$50K |
| ◆ insider | 2026-02-19 | Busch Matthew C. Other | SELL | $376K |
| Congress | 2026-01-29 | David Taylor | SELL | $1K–$15K |
| Congress | 2026-01-16 | David Taylor | BUY | $1K–$15K |
| Congress | 2025-12-03 | David Taylor | SELL | $1K–$15K |
| Congress | 2025-12-03 | David Taylor | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded AMGN?
72 disclosed buys and 52 sells of AMGN (Amgen Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade AMGN?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.